{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T02:07:49Z","timestamp":1778465269649,"version":"3.51.4"},"reference-count":59,"publisher":"Elsevier BV","issue":"52","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.vaccine.2007.10.039","type":"journal-article","created":{"date-parts":[[2007,11,6]],"date-time":"2007-11-06T12:20:25Z","timestamp":1194351625000},"page":"8741-8755","source":"Crossref","is-referenced-by-count":30,"title":["Generation of a recombinant Oka varicella vaccine expressing mumps virus hemagglutinin-neuraminidase protein as a polyvalent live vaccine"],"prefix":"10.1016","volume":"25","author":[{"given":"Pranee","family":"Somboonthum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Yoshii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigefumi","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Koike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Gomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiaki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Yamanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuko","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.10.039_bib1","series-title":"Varicella-zoster virus","author":"Arvin","year":"2001"},{"issue":"1","key":"10.1016\/j.vaccine.2007.10.039_bib2","first-page":"25","article-title":"Development of a live attenuated varicella vaccine","volume":"18","author":"Takahashi","year":"1975","journal-title":"Biken J"},{"key":"10.1016\/j.vaccine.2007.10.039_bib3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1146\/annurev.micro.50.1.59","article-title":"Live attenuated varicella vaccine","volume":"50","author":"Arvin","year":"1996","journal-title":"Annu Rev Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2007.10.039_bib4","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1542\/peds.75.4.667","article-title":"Long-term protective immunity of recipients of the OKA strain of live varicella vaccine","volume":"75","author":"Asano","year":"1985","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.vaccine.2007.10.039_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00008480-199902000-00002","article-title":"Update on varicella vaccine","volume":"11","author":"Kamiya","year":"1999","journal-title":"Curr Opin Pediatr"},{"issue":"3","key":"10.1016\/j.vaccine.2007.10.039_bib6","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0891-5520(05)70309-3","article-title":"The varicella vaccine. Vaccine development","volume":"10","author":"Takahashi","year":"1996","journal-title":"Infect Dis Clin North Am"},{"issue":"12","key":"10.1016\/j.vaccine.2007.10.039_bib7","doi-asserted-by":"crossref","first-page":"8109","DOI":"10.1128\/JVI.69.12.8109-8113.1995","article-title":"Immunization with recombinant varicella-zoster virus expressing herpes simplex virus type 2 glycoprotein D reduces the severity of genital herpes in guinea pigs","volume":"69","author":"Heineman","year":"1995","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2007.10.039_bib8","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1073\/pnas.84.11.3896","article-title":"Varicella-zoster virus as a live vector for the expression of foreign genes","volume":"84","author":"Lowe","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Pt 6","key":"10.1016\/j.vaccine.2007.10.039_bib9","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1099\/0022-1317-72-6-1393","article-title":"Development of immunogenic recombinant Oka varicella vaccine expressing hepatitis B virus surface antigen","volume":"72","author":"Shiraki","year":"1991","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.10.039_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/jmv.1022","article-title":"Construction of Oka varicella vaccine expressing human immunodeficiency virus env antigen","volume":"64","author":"Shiraki","year":"2001","journal-title":"J Med Virol"},{"issue":"29\/30","key":"10.1016\/j.vaccine.2007.10.039_bib11","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1016\/j.vaccine.2004.03.062","article-title":"Cloning of the varicella-zoster virus genome as an infectious bacterial artificial chromosome in Escherichia coli","volume":"22","author":"Nagaike","year":"2004","journal-title":"Vaccine"},{"issue":"27","key":"10.1016\/j.vaccine.2007.10.039_bib12","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1016\/j.vaccine.2007.04.064","article-title":"Cloning of full length genome of varicella-zoster virus vaccine strain into a bacterial artificial chromosome and reconstitution of infectious virus","volume":"25","author":"Yoshii","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2007.10.039_bib13","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.virol.2005.09.057","article-title":"New viral vaccines","volume":"344","author":"Arvin","year":"2006","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2007.10.039_bib14","first-page":"32","article-title":"Prevention and treatment of VZV infections in patients with HIV","volume":"8","author":"Gershon","year":"2001","journal-title":"Herpes"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2007.10.039_bib15","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1093\/infdis\/166.Supplement_1.S58","article-title":"Immunization of the elderly and patients with collagen vascular diseases with live varicella vaccine and use of varicella skin antigen","volume":"166","author":"Takahashi","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.10.039_bib16","series-title":"Mumps virus","author":"Carbone","year":"2001"},{"issue":"1","key":"10.1016\/j.vaccine.2007.10.039_bib17","first-page":"25","article-title":"Vaccination against epidemic parotitis","volume":"6","author":"Midulla","year":"1984","journal-title":"Pediatr Med Chir"},{"issue":"19","key":"10.1016\/j.vaccine.2007.10.039_bib18","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.2165\/00003495-200363190-00012","article-title":"Measles, mumps, rubella vaccine (Priorix; GSK-MMR): a review of its use in the prevention of measles, mumps and rubella","volume":"63","author":"Wellington","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.vaccine.2007.10.039_bib19","unstructured":"Mumps virus vaccines. Weekly Epidemiol Rec 2001;76(45):346\u201355."},{"issue":"49\/50","key":"10.1016\/j.vaccine.2007.10.039_bib20","doi-asserted-by":"crossref","first-page":"7037","DOI":"10.1016\/j.vaccine.2006.06.049","article-title":"Mumps vaccine virus strains and aseptic meningitis","volume":"24","author":"Bonnet","year":"2006","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2007.10.039_bib21","first-page":"302","article-title":"Aseptic meningitis after vaccination against measles and mumps","volume":"8","author":"Cizman","year":"1989","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2007.10.039_bib22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/(SICI)1099-1557(199601)5:1<33::AID-PDS210>3.0.CO;2-7","article-title":"Aseptic meningitis following mumps vaccine. A retrospective survey by the French Regional Pharmacovigilance centres and by Pasteur-Merieux Serums & Vaccins","volume":"5","author":"Jonville-Bera","year":"1996","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"10.1016\/j.vaccine.2007.10.039_bib23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1442-200X.1996.tb03471.x","article-title":"Adverse events associated with MMR vaccines in Japan","volume":"38","author":"Kimura","year":"1996","journal-title":"Acta Paediatr Jpn"},{"issue":"8851","key":"10.1016\/j.vaccine.2007.10.039_bib24","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/0140-6736(93)91069-X","article-title":"Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children","volume":"341","author":"Miller","year":"1993","journal-title":"Lancet"},{"issue":"8676","key":"10.1016\/j.vaccine.2007.10.039_bib25","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/S0140-6736(89)92004-7","article-title":"Mumps vaccine complications: which strain?","volume":"2","author":"Nalin","year":"1989","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2007.10.039_bib26","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00006454-199103000-00008","article-title":"Aseptic meningitis as a complication of mumps vaccination","volume":"10","author":"Sugiura","year":"1991","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2007.10.039_bib27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/01.inf.0000195626.35239.58","article-title":"Immunogenicity and safety of two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children","volume":"25","author":"Knuf","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"3\/4","key":"10.1016\/j.vaccine.2007.10.039_bib28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0264-410X(02)00459-0","article-title":"Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine","volume":"21","author":"Nolan","year":"2002","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2007.10.039_bib29","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/01.inf.0000172902.25009.a1","article-title":"Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children","volume":"24","author":"Shinefield","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"10.1016\/j.vaccine.2007.10.039_bib30","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1097\/01.inf.0000172901.29621.e9","article-title":"Dose-response study of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children","volume":"24","author":"Shinefield","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.vaccine.2007.10.039_bib31","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jaci.2006.07.033","article-title":"Mumps resurgence in the United States","volume":"118","author":"Kancherla","year":"2006","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2007.10.039_bib32","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/1096-9071(200008)61:4<497::AID-JMV13>3.0.CO;2-2","article-title":"Oka varicella vaccine is distinguishable from its parental virus in DNA sequence of open reading frame 62 and its transactivation activity","volume":"61","author":"Gomi","year":"2000","journal-title":"J Med Virol"},{"issue":"Pt 2","key":"10.1016\/j.vaccine.2007.10.039_bib33","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1099\/0022-1317-61-2-255","article-title":"Polypeptides of varicella-zoster virus (VZV) and immunological relationship of VZV and herpes simplex virus (HSV)","volume":"61","author":"Shiraki","year":"1982","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.10.039_bib34","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0042-6822(83)90175-7","article-title":"Synthesis and processing of glycoproteins of Varicella-Zoster virus (VZV) as studied with monoclonal antibodies to VZV antigens","volume":"129","author":"Okuno","year":"1983","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.vaccine.2007.10.039_bib35","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.1093\/nar\/29.3.e14","article-title":"A new method for generating point mutations in bacterial artificial chromosomes by homologous recombination in Escherichia coli","volume":"29","author":"Lalioti","year":"2001","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/j.vaccine.2007.10.039_bib36","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1128\/JVI.77.2.1382-1391.2003","article-title":"Construction of an excisable bacterial artificial chromosome containing a full-length infectious clone of herpes simplex virus type 1: viruses reconstituted from the clone exhibit wild-type properties in vitro and in vivo","volume":"77","author":"Tanaka","year":"2003","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.10.039_bib37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0166-0934(03)00225-8","article-title":"An efficient method for precise gene substitution in the AcMNPV genome by homologous recombination in E. coli","volume":"113","author":"Wu","year":"2003","journal-title":"J Virol Methods"},{"issue":"Pt 12","key":"10.1016\/j.vaccine.2007.10.039_bib38","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1099\/vir.0.19387-0","article-title":"Generation and precise modification of a herpesvirus saimiri bacterial artificial chromosome demonstrates that the terminal repeats are required for both virus production and episomal persistence","volume":"84","author":"White","year":"2003","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.10.039_bib39","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1083\/jcb.57.2.551","article-title":"A technique for ultracryotomy of cell suspensions and tissues","volume":"57","author":"Tokuyasu","year":"1973","journal-title":"J Cell Biol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.10.039_bib40","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF02473201","article-title":"Improving structural integrity of cryosections for immunogold labeling","volume":"106","author":"Liou","year":"1996","journal-title":"Histochem Cell Biol"},{"issue":"20","key":"10.1016\/j.vaccine.2007.10.039_bib41","doi-asserted-by":"crossref","first-page":"13037","DOI":"10.1128\/JVI.79.20.13037-13046.2005","article-title":"Human herpesvirus 6 open reading frame U14 protein and cellular p53 interact with each other and are contained in the virion","volume":"79","author":"Takemoto","year":"2005","journal-title":"J Virol"},{"issue":"22","key":"10.1016\/j.vaccine.2007.10.039_bib42","doi-asserted-by":"crossref","first-page":"11447","DOI":"10.1128\/JVI.76.22.11447-11459.2002","article-title":"Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus","volume":"76","author":"Gomi","year":"2002","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.10.039_bib43","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1128\/IAI.37.2.407-412.1982","article-title":"Experimental infection and immune response of guinea pigs with varicella-zoster virus","volume":"37","author":"Matsunaga","year":"1982","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2007.10.039_bib44","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/infdis\/142.3.414","article-title":"Experimental infection of guinea pigs with varicella-zoster virus","volume":"142","author":"Myers","year":"1980","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2007.10.039_bib45","first-page":"53","article-title":"Immune response of guinea pigs to varicella vaccine strain (OKA) and wild strains","volume":"23","author":"Yamanishi","year":"1980","journal-title":"Biken J"},{"issue":"Pt 11","key":"10.1016\/j.vaccine.2007.10.039_bib46","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1099\/0022-1317-82-11-2761","article-title":"Characterization of the DNA polymerase gene of varicella-zoster viruses resistant to acyclovir","volume":"82","author":"Kamiyama","year":"2001","journal-title":"J Gen Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.10.039_bib47","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.antiviral.2004.10.002","article-title":"Comparative efficacy of acyclovir and vidarabine on the replication of varicella-zoster virus","volume":"65","author":"Miwa","year":"2005","journal-title":"Antiviral Res"},{"issue":"15","key":"10.1016\/j.vaccine.2007.10.039_bib48","doi-asserted-by":"crossref","first-page":"7376","DOI":"10.1073\/pnas.90.15.7376","article-title":"Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro","volume":"90","author":"Cohen","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2007.10.039_bib49","series-title":"Varicella-zoster virus and its replication","author":"Cohen","year":"2001"},{"issue":"2","key":"10.1016\/j.vaccine.2007.10.039_bib50","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1006\/viro.2002.1556","article-title":"The requirement of varicella zoster virus glycoprotein E (gE) for viral replication and effects of glycoprotein I on gE in melanoma cells","volume":"304","author":"Mo","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2007.10.039_bib51","series-title":"Paramyxoviridae: the viruses and their replication","author":"Lamb","year":"2001"},{"issue":"1\/2","key":"10.1016\/j.vaccine.2007.10.039_bib52","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0168-1702(00)00254-9","article-title":"Localization of a new neutralizing epitope on the mumps virus hemagglutinin-neuraminidase protein","volume":"74","author":"Cusi","year":"2001","journal-title":"Virus Res"},{"issue":"3","key":"10.1016\/j.vaccine.2007.10.039_bib53","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1128\/JVI.53.3.727-734.1985","article-title":"Protective effects of glycoprotein-specific monoclonal antibodies on the course of experimental mumps virus meningoencephalitis","volume":"53","author":"Wolinsky","year":"1985","journal-title":"J Virol"},{"issue":"Pt 5","key":"10.1016\/j.vaccine.2007.10.039_bib54","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1099\/0022-1317-68-5-1449","article-title":"Varicella-zoster virus specifies a thymidylate synthetase","volume":"68","author":"Thompson","year":"1987","journal-title":"J Gen Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.10.039_bib55","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s007050050007","article-title":"Stability of a varicella-zoster virus glycoprotein E epitope","volume":"145","author":"Vafai","year":"2000","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2007.10.039_bib56","doi-asserted-by":"crossref","DOI":"10.1007\/s10529-007-9490-7","article-title":"Cell-specific effects of human cytomegalovirus unique region on recombinant protein expression","author":"Lee","year":"2007","journal-title":"Biotechnol Lett"},{"issue":"2","key":"10.1016\/j.vaccine.2007.10.039_bib57","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0378-1119(95)00767-9","article-title":"Efficiency of different viral promoters in directing gene expression in mammalian cells: effect of 3\u2032-untranslated sequences","volume":"168","author":"Rotondaro","year":"1996","journal-title":"Gene"},{"issue":"24","key":"10.1016\/j.vaccine.2007.10.039_bib58","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1007\/s00018-004-4269-7","article-title":"The role of the trans-Golgi network in varicella zoster virus biology","volume":"61","author":"Hambleton","year":"2004","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.vaccine.2007.10.039_bib59","series-title":"Active immunization for varicella-zoster virus","author":"Takahashi","year":"1981"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07012017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07012017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T16:40:55Z","timestamp":1684082455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07012017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":59,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0264410X07012017"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.10.039","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}